North Carolina HIV/STD Quarterly Surveillance Report: Vol. 2007, No. 3 Epidemiology & Special Studies Unit

HIV/STD Prevention and Care Branch 1902 Mail Service Center Epidemiology Section, Division of Public Health Raleigh, North Carolina 27699-1902 North Carolina Department of Health & Human Services (919) 733-7301

ANNOUNCEMENTS: Readers are cautioned that these data represent reports for short time periods and that changes noted from quarter to quarter may not be meaningful. Reporting delays and changes can substantially affect counts. Reports are counted by county of residence for the case. For persons diagnosed in long-term institutions such as prisons and some treatment facilities, the institution is considered the cases’ address. Disease counts for counties with such facilities may be higher than expected otherwise. Readers will also note that HIV disease reports for 2006 are up significantly compared to the same period in earlier years. In recent years, laboratory reporting in North Carolina has been enhanced with the addition of required reporting of HIV viral load results and certain CD4 results. Follow up surveillance activities for these laboratory reports is given a high priority. Thus, this increase in 2006 reports may be the result of enhanced surveillance activities as well as a general increase in the number of new HIV diagnoses. If you have questions or comments, please contact us at the address or phone number above.

About the authors North Carolina law requires that diagnoses of certain communicable diseases, including sexually transmitted diseases (STDs), be reported to local health departments that in turn report the information to the state. The Epidemiology and Special Studies Unit (ESSU) is the designated recipient for STD morbidity reports at the state level and is responsible for aggregating reports and providing statewide information about these diseases to others, including the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. The ESSU is part of the HIV/STD Prevention and Care Branch within the North Carolina Division of Public Health.

About the contents of this report The North Carolina HIV/STD Surveillance Report: Vol. 2007, No.3 presents statistics and trends of sexually transmitted diseases (including HIV and AIDS) in North Carolina from January 1 through September 30, 2007. All reports are presented by the date received by the ESSU. This report is intended as a reference document for local health departments, program managers, health planners, researchers and others who are concerned with the public health implications of these diseases. The information in this quarterly report is meant to be brief and provide limited data on these diseases throughout the year. More detailed and complete information will continue to be available in annual publications. This report and our annual publications are available on our website (www.epi.state.nc.us/epi/hiv/surveillance.html). The CDC maintains data about these diseases for the United States; national information is available from its website (www.cdc.gov).

State of North Carolina ● Michael F. Easley, Governor

Department of Health & Human Services ● Division of Public Health NC DHHS is an equal opportunity employer and provider. www.ncdhhs.gov

10/07

10/07

NC HIV/STD Quarterly Surveillance Report Vol. 2007 No. 3

NCDHHS HIV/STD Prev. & Care 2

AIDS and HIV disease surveillance data HIV disease case reports represent persons who have a confirmed diagnosis with human immunodeficiency virus (HIV). This category represents all new diagnoses with HIV regardless of the stage of the disease. Most persons are reported with only an HIV infection, but some persons are reported with a concurrent diagnosis of AIDS (acquired immunodeficiency syndrome). In North Carolina, about one-third of the new HIV disease reports represent persons who are diagnosed with HIV infection and AIDS at the same time. AIDS case reports, by contrast, represent only persons with HIV infection who have progressed to this later, more life threatening, stage of disease. Most AIDS case reports represent persons who were diagnosed with HIV infection in earlier years. For these reasons, HIV disease reports and AIDS case reports should be considered separately. The two categories should never be combined to estimate an infected population, as the broad group of HIV disease includes AIDS cases but the time references are different. Chlamydia surveillance data Chlamydia case reports represent persons who have a laboratory-confirmed chlamydial infection. It is important to note that chlamydial infection is often asymptomatic in both males and females, and most cases are detected through screening. Changes in the number of reported cases may be due to changes in screening practices. The disease can cause serious complications in females, and a number of screening programs are in place to detect infection in young women. There are no comparable screening programs for young men. For this reason, chlamydia case reports are always highly biased with respect to gender. Gonorrhea surveillance data Gonorrhea case reports represent persons who have a laboratory-confirmed gonorrhea infection. Gonorrhea is often symptomatic in males and slightly less so in females. Many cases are detected when patients seek medical care. Others are detected through screening but to a far lesser degree than chlamydia cases. Gonorrhea can cause serious complications for females and a number of screening programs exist targeting this population. There is less screening of males but since they are more likely to have symptoms that would bring them to the STD clinic, gender bias in gonorrhea reporting is not likely to be large. Public clinics and health departments may do a better job of conducting such screening programs and reporting cases, causing the reported cases to be biased toward those attending public clinics. Syphilis surveillance data Syphilis cases are reported by stage of infection, which is determined through a combination of laboratory testing and patient interviews. Primary and secondary syphilis have very specific symptoms associated with them, so misclassification of these stages is highly unlikely. Early latent syphilis is asymptomatic but can be staged with confirmation that the infection is less than a year old. Together these three stages that occur within the first year of infection are called ‘early syphilis’. This report includes only early syphilis cases, though other later stages are reported to ESSU. Because North Carolina performs patient interviews, partner notification, and contact tracing on all early syphilis cases, the quality of the early latent case data is also quite good. Screening programs are more likely to detect asymptomatic cases, which may introduce some bias in the early latent case reports toward screened populations (pregnant women, jail inmates, others). But, thorough contact tracing further aids in case detection and reduces these biases. For more information The data descriptions provided on this page are succinct. For a more detailed discussion of the content, strengths, and weaknesses of STD and HIV surveillance data, please see pages 131-148 in the Epidemiologic Profile for HIV/STD Prevention & Care Planning, August 2006. This report can be found on our website www.epi.state.nc.us/epi/hiv/epiprofile0806.html .

NC HIV/STD Quarterly Surveillance Report Vol. 2007 No. 3

NCDHHS HIV/STD Prev. & Care 3

NORTH CAROLINA HIV DISEASE † CASES

COUNTY 2005 Jan-Sep

2006 Jan-Sep

2007 Jan-Sep

ALAMANCE 26 14 14ALEXANDER 3 2 0ALLEGHANY 0 0 2ANSON 1 5 0ASHE 0 2 3AVERY 0 0 1BEAUFORT 3 5 3BERTIE 4 2 5BLADEN 2 4 2BRUNSWICK 6 8 6BUNCOMBE 8 21 31BURKE 6 1 1CABARRUS 16 9 10CALDWELL 5 3 0CAMDEN 1 1 1CARTERET 0 3 3CASWELL 0 2 4CATAWBA 6 14 3CHATHAM 2 0 4CHEROKEE 2 2 3CHOWAN 3 0 1CLAY 0 0 0CLEVELAND 24 10 9COLUMBUS 10 12 10CRAVEN 11 23 17CUMBERLAND 50 104 51CURRITUCK 1 2 2DARE 1 2 0DAVIDSON 14 9 5DAVIE 2 2 0DUPLIN 7 10 9DURHAM 74 78 66EDGECOMBE 14 23 22FORSYTH 72 71 57FRANKLIN 6 11 2GASTON 19 30 12GATES 0 1 0GRAHAM 0 0 0GRANVILLE 13 5 6GREENE 1 6 1GUILFORD 88 124 94HALIFAX 8 8 6HARNETT 5 19 3HAYWOOD 5 2 5HENDERSON 2 3 3HERTFORD 9 80 14HOKE 1 12 5HYDE 0 0 0IREDELL 11 10 4JACKSON 0 5 0JOHNSTON 14 24 9JONES 1 0 0LEE 4 10 5

NORTH CAROLINA HIV DISEASE † CASES

COUNTY 2005 Jan-Sep

2006 Jan-Sep

2007 Jan-Sep

LENOIR 14 19 18LINCOLN 2 2 1MACON 2 1 1MADISON 0 2 0MARTIN 5 7 7MCDOWELL 2 4 1MECKLENBURG 239 321 260MITCHELL 0 0 1MONTGOMERY 3 0 4MOORE 12 11 8NASH 15 21 16NEW HANOVER 42 49 27NORTHAMPTON 1 3 3ONSLOW 12 10 10ORANGE 11 15 8PAMLICO 2 2 1PASQUOTANK 2 11 3PENDER 4 3 1PERQUIMANS 2 1 0PERSON 0 1 8PITT 23 19 22POLK 0 0 0RANDOLPH 7 7 7RICHMOND 8 11 13ROBESON 28 23 30ROCKINGHAM 8 4 2ROWAN 19 11 16RUTHERFORD 2 7 0SAMPSON 8 17 4SCOTLAND 6 7 5STANLY 1 4 5STOKES 5 1 2SURRY 9 2 2SWAIN 0 0 0TRANSYLVANIA 1 1 2TYRRELL 0 0 0UNION 6 8 12VANCE 5 6 10WAKE 138 201 148WARREN 2 4 1WASHINGTON 7 2 6WATAUGA 4 2 0WAYNE 14 26 20WILKES 2 2 3WILSON 20 20 13YADKIN 2 2 0YANCEY 0 0 1UNKNOWN 0 2 9TOTAL 1,256 1,666 1,225

†HIV Disease includes all newly reported HIV infected individuals by the date of first report (HIV or AIDS)

NC HIV/STD Quarterly Surveillance Report Vol. 2007 No. 3

NCDHHS HIV/STD Prev. & Care 4

NORTH CAROLINA SEXUALLY TRANSMITTED DISEASE CASES CHLAMYDIA GONORRHEA P. & S. SYPHILIS E. L. SYPHILIS

YEAR TO DATE 2005 Jan-Sep

2006 Jan-Sep

2007 Jan-Sep

2005 Jan-Sep

2006 Jan-Sep

2007 Jan-Sep

2005 Jan-Sep

2006 Jan-Sep

2007 Jan-Sep

2005 Jan-Sep

2006 Jan-Sep

2007 Jan-Sep

ALAMANCE 302 280 334 124 168 159 3 3 5 0 3 1ALEXANDER 37 38 27 7 17 10 1 0 0 1 0 0ALLEGHANY 0 0 2 0 0 0 0 0 0 0 0 0ANSON 137 67 96 65 58 56 0 0 0 0 1 0ASHE 9 15 9 1 0 1 0 0 0 0 0 0AVERY 3 4 5 0 0 0 0 0 0 0 0 0BEAUFORT 129 130 137 34 59 61 0 0 0 0 1 0BERTIE 115 107 85 73 59 37 0 0 0 0 1 0BLADEN 107 129 104 35 48 24 1 0 0 2 3 0BRUNSWICK 125 156 164 99 107 57 1 1 1 1 1 3BUNCOMBE 448 407 423 178 251 144 2 3 3 3 1 2BURKE 88 110 90 38 77 39 0 0 2 3 0 0CABARRUS 319 281 425 114 136 160 3 3 1 0 1 1CALDWELL 118 96 111 28 38 65 0 0 0 0 0 0CAMDEN 10 11 15 6 4 4 0 0 0 0 0 0CARTERET 85 96 100 64 58 27 0 0 0 0 0 2CASWELL 57 59 23 16 27 17 0 0 0 0 0 0CATAWBA 258 325 289 103 170 148 1 0 2 0 0 0CHATHAM 46 60 61 33 28 30 1 1 1 2 0 0CHEROKEE 10 11 33 1 1 1 0 0 0 1 0 0CHOWAN 38 48 38 22 48 21 0 0 0 0 0 0CLAY 4 4 6 0 1 2 0 0 0 0 0 0CLEVELAND 319 253 242 236 170 132 3 2 2 2 0 1COLUMBUS 169 180 116 101 100 51 1 0 0 1 1 2CRAVEN 473 453 310 141 134 81 0 1 6 0 1 5CUMBERLAND 1,983 1,530 1,743 735 661 900 8 11 9 6 8 3CURRITUCK 23 30 26 5 28 8 0 0 0 0 0 0DARE 50 45 41 15 12 10 0 0 0 0 0 0DAVIDSON 224 219 239 114 83 93 1 0 0 0 1 1DAVIE 46 63 38 25 24 24 1 1 0 0 0 1DUPLIN 114 149 150 38 90 54 0 0 0 0 1 2DURHAM 1,093 950 804 554 538 438 8 9 23 2 13 13EDGECOMBE 389 388 379 253 279 229 0 3 2 0 2 6FORSYTH 1,339 1,406 1,626 519 612 554 5 6 5 6 17 9FRANKLIN 68 117 110 40 55 57 1 0 1 0 0 3GASTON 613 489 527 449 368 240 1 8 4 4 4 2GATES 41 32 24 20 18 9 0 0 0 0 0 0GRAHAM 1 4 4 0 0 0 0 0 0 0 0 0GRANVILLE 134 178 123 47 76 40 0 0 1 0 0 0GREENE 74 52 77 49 31 39 0 0 1 0 0 1GUILFORD 1,369 1,477 1,680 643 813 1,033 27 15 18 21 32 12HALIFAX 316 333 362 162 158 162 1 2 1 1 0 2HARNETT 180 192 187 92 125 98 0 0 0 0 1 1HAYWOOD 54 50 49 8 3 9 0 0 0 0 0 0HENDERSON 122 125 106 34 65 35 0 0 0 0 0 0HERTFORD 65 127 73 37 66 25 0 1 0 0 0 0HOKE 132 77 83 49 34 22 0 0 0 0 0 0HYDE 9 7 12 3 2 2 0 1 0 0 0 0IREDELL 231 251 233 151 214 162 0 2 0 0 1 1JACKSON 39 35 48 5 5 7 0 0 0 0 0 0JOHNSTON 135 267 190 68 152 99 1 6 5 2 1 5

NC HIV/STD Quarterly Surveillance Report Vol. 2007 No. 3

NCDHHS HIV/STD Prev. & Care 5

NORTH CAROLINA SEXUALLY TRANSMITTED DISEASE CASES CHLAMYDIA GONORRHEA P. & S. SYPHILIS E. L. SYPHILIS

YEAR TO DATE 2005 Jan-Sep

2006 Jan-Sep

2007 Jan-Sep

2005 Jan-Sep

2006 Jan-Sep

2007 Jan-Sep

2005 Jan-Sep

2006 Jan-Sep

2007 Jan-Sep

2005 Jan-Sep

2006 Jan-Sep

2007 Jan-Sep

JONES 24 21 27 15 8 9 1 0 0 0 0 0LEE 115 143 126 66 83 41 2 1 0 0 2 0LENOIR 294 246 242 183 150 112 4 0 3 1 1 2LINCOLN 55 73 84 23 32 17 0 0 1 0 0 0MACON 32 21 26 2 3 1 0 0 0 1 0 0MADISON 16 27 14 3 1 3 0 0 0 0 0 0MARTIN 82 118 101 48 69 27 0 2 1 0 0 0MCDOWELL 30 40 38 6 5 20 1 0 0 1 0 1MECKLENBURG 2,708 2,098 1,310 1,513 1,562 717 67 74 70 42 67 28MITCHELL 5 10 8 1 2 0 0 0 0 0 0 0MONTGOMERY 28 32 45 21 22 14 1 0 0 0 1 0MOORE 186 172 161 51 84 50 0 0 2 1 1 0NASH 295 347 334 147 222 201 2 5 6 1 8 6NEW HANOVER 610 585 524 266 274 207 2 7 13 4 4 16NORTHAMPTON 119 118 118 50 60 43 0 2 0 0 1 0ONSLOW 716 965 725 301 307 127 0 1 1 0 1 1ORANGE 193 232 180 87 81 60 0 1 4 0 1 2PAMLICO 14 30 20 4 8 2 0 0 0 0 0 0PASQUOTANK 148 127 112 96 83 63 0 0 0 0 0 0PENDER 114 107 82 47 45 31 0 0 0 0 0 1PERQUIMANS 47 20 38 22 17 14 0 1 0 0 1 0PERSON 86 68 64 40 27 31 0 3 0 0 0 0PITT 712 671 661 406 390 299 1 1 3 0 3 2POLK 14 16 22 6 4 6 0 0 0 0 0 0RANDOLPH 162 144 171 58 62 40 6 1 0 4 2 1RICHMOND 151 146 149 48 94 83 0 0 0 0 0 0ROBESON 731 624 592 399 317 291 6 0 5 9 4 8ROCKINGHAM 188 182 165 90 95 76 1 2 2 1 0 2ROWAN 389 351 280 148 164 134 2 0 2 0 0 1RUTHERFORD 127 123 121 111 108 72 0 0 0 0 0 1SAMPSON 138 128 128 82 89 101 0 0 1 1 1 2SCOTLAND 148 148 176 90 109 92 1 0 1 0 0 0STANLY 98 94 78 67 46 31 0 0 2 1 1 1STOKES 23 7 64 7 3 16 2 0 0 0 0 0SURRY 57 56 49 16 18 6 0 2 0 1 1 0SWAIN 32 37 27 8 3 0 0 0 0 0 0 0TRANSYLVANIA 56 27 18 20 12 14 0 0 1 0 0 0TYRRELL 12 6 11 4 4 2 0 0 0 0 0 0UNION 247 184 157 141 114 109 3 3 0 1 0 0VANCE 178 314 208 91 132 112 0 0 0 2 3 0WAKE 1,896 3,162 2,072 724 1,208 704 22 26 22 18 23 10WARREN 68 87 94 27 37 39 1 0 0 0 0 0WASHINGTON 37 54 56 26 35 15 1 0 0 0 0 0WATAUGA 33 19 12 3 5 1 0 1 0 0 0 0WAYNE 411 361 266 170 168 80 2 6 7 2 4 5WILKES 30 54 51 11 17 4 1 0 0 0 0 0WILSON 328 346 342 278 331 269 3 5 1 1 0 2YADKIN 32 40 40 17 13 16 2 0 1 0 0 0YANCEY 5 13 8 2 4 2 0 0 0 0 0 0UNKNOWN 0 0 0 0 0 0 0 0 0 0 0 0TOTAL 24,470 24,907 22,576 11,676 12,998 10,080 205 223 242 150 225 171

NC HIV/STD Quarterly Surveillance Report Vol. 2007 No. 3

NCDHHS HIV/STD Prev. & Care 6

NORTH CAROLINA AIDS* CASES

COUNTY 2005 Jan-Sep

2006 Jan-Sep

2007 Jan-Sep

ALAMANCE 11 2 7ALEXANDER 1 3 0ALLEGHANY 0 0 0ANSON 5 1 3ASHE 0 1 0AVERY 0 0 1BEAUFORT 4 2 1BERTIE 5 3 3BLADEN 1 5 2BRUNSWICK 2 7 3BUNCOMBE 7 8 7BURKE 3 3 0CABARRUS 1 6 6CALDWELL 2 0 0CAMDEN 1 1 0CARTERET 0 1 1CASWELL 0 1 2CATAWBA 4 7 5CHATHAM 1 0 1CHEROKEE 0 2 1CHOWAN 2 2 0CLAY 0 0 0CLEVELAND 6 8 7COLUMBUS 3 10 8CRAVEN 11 23 17CUMBERLAND 21 37 33CURRITUCK 0 1 0DARE 0 0 0DAVIDSON 4 0 3DAVIE 0 2 0DUPLIN 3 5 2DURHAM 32 31 25EDGECOMBE 10 5 10FORSYTH 27 23 22FRANKLIN 4 4 3GASTON 18 8 7GATES 0 1 0GRAHAM 0 0 0GRANVILLE 8 4 3GREENE 1 2 1GUILFORD 30 35 36HALIFAX 3 10 4HARNETT 7 8 4HAYWOOD 4 2 1HENDERSON 2 1 4HERTFORD 0 26 8HOKE 1 5 2HYDE 0 0 0IREDELL 6 4 3JACKSON 0 1 0JOHNSTON 9 18 6JONES 0 1 0LEE 1 5 5

NORTH CAROLINA AIDS* CASES

COUNTY 2005 Jan-Sep

2006 Jan-Sep

2007 Jan-Sep

LENOIR 10 8 9LINCOLN 2 3 0MACON 0 0 0MADISON 0 0 0MARTIN 4 4 2MCDOWELL 3 1 2MECKLENBURG 105 143 132MITCHELL 0 0 1MONTGOMERY 3 0 0MOORE 2 5 5NASH 10 8 14NEW HANOVER 16 27 15NORTHAMPTON 2 1 1ONSLOW 4 3 3ORANGE 4 5 3PAMLICO 1 0 0PASQUOTANK 1 4 2PENDER 3 1 1PERQUIMANS 3 0 1PERSON 0 0 6PITT 16 14 17POLK 0 0 1RANDOLPH 3 6 4RICHMOND 4 4 6ROBESON 18 11 20ROCKINGHAM 1 1 3ROWAN 5 9 7RUTHERFORD 4 0 1SAMPSON 4 9 6SCOTLAND 4 3 3STANLY 2 1 3STOKES 0 0 2SURRY 2 0 0SWAIN 0 1 0TRANSYLVANIA 0 1 1TYRRELL 0 0 1UNION 3 8 7VANCE 4 5 7WAKE 78 122 101WARREN 1 1 0WASHINGTON 1 3 3WATAUGA 2 1 0WAYNE 10 27 14WILKES 0 1 2WILSON 13 15 11YADKIN 0 2 0YANCEY 0 1 1UNKNOWN 0 1 23TOTAL 609 795 698

*includes all AIDS cases by date of report for an AIDS diagnosis

NC

HIV

/STD

Qua

rterly

Sur

veill

ance

Rep

ort V

ol. 2

007

No.

3

NC

DH

HS

H

IV/S

TD P

rev.

& C

are

7

Nor

th C

arol

ina

HIV

† Dis

ease

Cas

es b

y G

ende

r and

Age

, 200

7

1st Q

tr

2nd

Qtr

3r

d Q

tr

4th

Qtr

Ye

ar to

Dat

e A

GE

Cas

esPc

t C

ases

Pct

Cas

esPc

t C

ases

Pct

Cas

esPc

t

0-12

Yea

rs

2 0.

4%

1 0.

2%

1 0.

3%

n/a

n/a

4 0.

3%

13-1

9 Ye

ars

14

3.0%

15

3.

2%

11

3.8%

n/

a n/

a40

3.

3%

20-2

9 Ye

ars

87

18.4

%

83

17.9

%

52

18.1

%

n/a

n/a

222

18.1

%

30-3

9 Ye

ars

88

18.6

%

80

17.2

%

52

18.1

%

n/a

n/a

220

18.0

%

40-4

9 Ye

ars

86

18.2

%

95

20.5

%

57

19.8

%

n/a

n/a

238

19.4

%

50 a

nd o

ver

59

12.5

%

54

11.6

%

35

12.2

%

n/a

n/a

148

12.1

%

Unk

now

n n/

a 0.

0%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

n/a

0.0%

Mal

e

Tota

l 33

6 71

.0%

32

8 70

.7%

20

8 72

.2%

n/

a n/

a87

2 71

.2%

0-12

Yea

rs

n/a

0.0%

2

0.4%

n/

a 0.

0%

n/a

n/a

2 0.

2%

13-1

9 Ye

ars

8 1.

7%

6 1.

3%

2 0.

7%

n/a

n/a

16

1.3%

20-2

9 Ye

ars

31

6.6%

28

6.

0%

15

5.2%

n/

a n/

a74

6.

0%

30-3

9 Ye

ars

32

6.8%

40

8.

6%

32

11.1

%

n/a

n/a

104

8.5%

40-4

9 Ye

ars

38

8.0%

33

7.

1%

18

6.3%

n/

a n/

a89

7.

3%

50 a

nd o

ver

28

5.9%

27

5.

8%

13

4.5%

n/

a n/

a68

5.

6%

Unk

now

n n/

a 0.

0%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

n/a

0.0%

Fem

ale

Tota

l 13

7 29

.0%

13

6 29

.3%

80

27

.8%

n/

a n/

a35

3 28

.8%

0-12

Yea

rs

2 0.

4%

3 0.

6%

1 0.

3%

n/a

n/a

6 0.

5%

13-1

9 Ye

ars

22

4.7%

21

4.

5%

13

4.5%

n/

a n/

a56

4.

6%

20-2

9 Ye

ars

118

24.9

%

111

23.9

%

67

23.3

%

n/a

n/a

296

24.2

%

30-3

9 Ye

ars

120

25.4

%

120

25.9

%

84

29.2

%

n/a

n/a

324

26.4

%

40-4

9 Ye

ars

124

26.2

%

128

27.6

%

75

26.0

%

n/a

n/a

327

26.7

%

50 a

nd o

ver

87

18.4

%

81

17.5

%

48

16.7

%

n/a

n/a

216

17.6

%

Unk

now

n n/

a 0.

0%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

n/a

0.0%

Tota

l

Tota

l 47

3 10

0.0%

464

100.

0%28

8 10

0.0%

n/

a n/

a1,

225

100.

0%† H

IV D

isea

se in

clud

es a

ll ne

wly

repo

rted

HIV

infe

cted

indi

vidu

als

by th

e da

te o

f firs

t rep

ort (

HIV

or A

IDS

)

NC

HIV

/STD

Qua

rterly

Sur

veill

ance

Rep

ort V

ol. 2

007

No.

3

NC

DH

HS

H

IV/S

TD P

rev.

& C

are

8

Nor

th C

arol

ina

HIV

† Dis

ease

Cas

es b

y G

ende

r and

Rac

e/Et

hnic

ity, 2

007

1s

t Qtr

2n

d Q

tr

3rd

Qtr

4t

h Q

tr

Year

to D

ate

RA

CE/

ETH

NIC

ITY

Cas

esPc

t C

ases

Pct

Cas

esPc

t C

ases

Pct

Cas

esPc

t

Whi

te**

10

1 21

.4%

10

6 22

.8%

64

22

.2%

n/

a n/

a27

1 22

.1%

Bla

ck**

19

0 40

.2%

18

9 40

.7%

12

4 43

.1%

n/

a n/

a50

3 41

.1%

Am

.In/A

N**

1 0.

2%

2 0.

4%

2 0.

7%

n/a

n/a

5 0.

4%

Asi

an,P

I**

2 0.

4%

1 0.

2%

1 0.

3%

n/a

n/a

4 0.

3%

His

pani

c 42

8.

9%

30

6.5%

16

5.

6%

n/a

n/a

88

7.2%

Unk

now

n n/

a 0.

0%

n/a

0.0%

1

0.3%

n/

a n/

a1

0.1%

Mal

e

Tota

l 33

6 71

.0%

32

8 70

.7%

20

8 72

.2%

n/

a n/

a87

2 71

.2%

Whi

te**

23

4.

9%

17

3.7%

10

3.

5%

n/a

n/a

50

4.1%

Bla

ck**

99

20

.9%

11

2 24

.1%

65

22

.6%

n/

a n/

a27

6 22

.5%

Am

.In/A

N**

2 0.

4%

2 0.

4%

1 0.

3%

n/a

n/a

5 0.

4%

Asi

an,P

I**

n/a

0.0%

n/

a 0.

0%

n/a

0.0%

n/

a n/

an/

a 0.

0%

His

pani

c 13

2.

7%

5 1.

1%

4 1.

4%

n/a

n/a

22

1.8%

Unk

now

n n/

a 0.

0%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

n/a

0.0%

Fem

ale

Tota

l 13

7 29

.0%

13

6 29

.3%

80

27

.8%

n/

a n/

a35

3 28

.8%

Whi

te**

12

4 26

.2%

12

3 26

.5%

74

25

.7%

n/

a n/

a32

1 26

.2%

Bla

ck**

28

9 61

.1%

30

1 64

.9%

18

9 65

.6%

n/

a n/

a77

9 63

.6%

Am

.In/A

N**

3 0.

6%

4 0.

9%

3 1.

0%

n/a

n/a

10

0.8%

Asi

an,P

I**

2 0.

4%

1 0.

2%

1 0.

3%

n/a

n/a

4 0.

3%

His

pani

c 55

11

.6%

35

7.

5%

20

6.9%

n/

a n/

a11

0 9.

0%

Unk

now

n n/

a 0.

0%

n/a

0.0%

1

0.3%

n/

a n/

a1

0.1%

Tota

l

Tota

l 47

3 10

0.0%

464

100.

0%28

8 10

0.0%

n/

a n/

a1,

225

100.

0%

**n

on H

ispa

nic;

Am

. In/

AN

= A

mer

ican

Indi

an/A

lask

an N

ativ

e; A

sian

, PI=

Asi

an/P

acifi

c Is

land

er

† H

IV D

isea

se in

clud

es a

ll ne

wly

repo

rted

HIV

infe

cted

indi

vidu

als

by th

e da

te o

f firs

t rep

ort (

HIV

or A

IDS

)

NC

HIV

/STD

Qua

rterly

Sur

veill

ance

Rep

ort V

ol. 2

007

No.

3

NC

DH

HS

HIV

/STD

Pre

v. &

Car

e

9

Nor

th C

arol

ina

HIV

† Dis

ease

Cas

es b

y G

ende

r and

Mod

e of

Tra

nsm

issi

on, 2

007

1st Q

tr

2nd

Qtr

3r

d Q

tr

4th

Qtr

Ye

ar to

Dat

e M

OD

E O

F TR

AN

SMIS

SIO

N

Cas

esPc

t C

ases

Pct

Cas

es

Pct

Cas

esPc

tC

ases

Pct

MSM

**

176

37.2

%

163

35.1

%

105

36.5

%

n/a

n/a

444

36.2

%

IDU

**

14

3.0%

9

1.9%

6

2.1%

n/

a n/

a29

2.

4%

MSM

/IDU

9

1.9%

7

1.5%

2

0.7%

n/

a n/

a18

1.

5%

Blo

od P

rodu

cts*

* n/

a 0.

0%

5 1.

1%

n/a

0.0%

n/

a n/

a5

0.4%

Het

eros

exua

l con

tact

11

2.

3%

17

3.7%

9

3.1%

n/

a n/

a37

3.

0%

Pres

umed

het

eros

exua

l35

7.

4%

36

7.8%

17

5.

9%

n/a

n/a

88

7.2%

Pedi

atric

2

0.4%

1

0.2%

1

0.3%

n/

a n/

a4

0.3%

Ris

k no

t spe

cifie

d 89

18

.8%

90

19

.4%

68

23

.6%

n/

a n/

a24

7 20

.2%

Mal

e

Tota

l 33

6 71

.0%

32

8 70

.7%

20

8 72

.2%

n/

a n/

a87

2 71

.2%

IDU

**

13

2.7%

5

1.1%

3

1.0%

n/

a n/

a21

1.

7%

Blo

od P

rodu

cts*

* 3

0.6%

2

0.4%

1

0.3%

n/

a n/

a6

0.5%

Het

eros

exua

l con

tact

28

5.

9%

26

5.6%

15

5.

2%

n/a

n/a

69

5.6%

Pres

umed

het

eros

exua

l44

9.

3%

28

6.0%

24

8.

3%

n/a

n/a

96

7.8%

Pedi

atric

n/

a 0.

0%

2 0.

4%

n/a

0.0%

n/

a n/

a2

0.2%

Ris

k no

t spe

cifie

d 49

10

.4%

73

15

.7%

37

12

.8%

n/

a n/

a15

9 13

.0%

Fem

ale

Tota

l 13

7 29

.0%

13

6 29

.3%

80

27

.8%

n/

a n/

a35

3 28

.8%

MSM

**

176

37.2

%

163

35.1

%

105

36.5

%

n/a

n/a

444

36.2

%

IDU

**

27

5.7%

14

3.

0%

9 3.

1%

n/a

n/a

50

4.1%

MSM

/IDU

9

1.9%

7

1.5%

2

0.7%

n/

a n/

a18

1.

5%

Blo

od P

rodu

cts*

* 3

0.6%

7

1.5%

1

0.3%

n/

a n/

a11

0.

9%

Het

eros

exua

l con

tact

39

8.

2%

43

9.3%

24

8.

3%

n/a

n/a

106

8.7%

Pres

umed

het

eros

exua

l79

16

.7%

64

13

.8%

41

14

.2%

n/

a n/

a18

4 15

.0%

Pedi

atric

2

0.4%

3

0.6%

1

0.3%

n/

a n/

a6

0.5%

Ris

k no

t spe

cifie

d 13

8 29

.2%

16

3 35

.1%

10

5 36

.5%

n/

a n/

a40

6 33

.1%

Tota

l

Tota

l 47

3 10

0.0%

464

100.

0%28

8 10

0.0%

n/a

n/a

1,22

510

0.0%

*

*MS

M=

men

who

hav

e se

x w

ith m

en; I

DU

= in

trave

nous

dru

g us

e; “B

lood

pro

duct

s” in

clud

es a

dult

hem

ophi

lia; “

Pre

sum

ed h

eter

osex

ual”

incl

udes

re

ports

initi

ally

cla

ssifi

ed a

s “r

isk

not

spec

ified

” w

ith a

dditi

onal

risk

info

rmat

ion

cons

iste

nt w

ith h

eter

osex

ual t

rans

mis

sion

;

†H

IV D

isea

se in

clud

es a

ll ne

wly

repo

rted

HIV

infe

cted

indi

vidu

als

by th

e da

te o

f firs

t rep

ort (

HIV

or A

IDS

)

NC

HIV

/STD

Qua

rterly

Sur

veill

ance

Rep

ort V

ol. 2

007

No.

3

NC

DH

HS

HIV

/STD

Pre

v. &

Car

e

10 N

orth

Car

olin

a C

hlam

ydia

Cas

es b

y G

ende

r and

Age

, 200

7

1st Q

tr

2nd

Qtr

3r

d Q

tr

4th

Qtr

Ye

ar to

Dat

e A

GE

Cas

esPc

t C

ases

Pct

Cas

esPc

t C

ases

Pct

Cas

esPc

t

0-12

Yea

rs

4 0.

1%

2 0.

0%

n/a

0.0%

n/

a n/

a6

0.0%

13-1

9 Ye

ars

323

4.2%

35

1 5.

0%

307

3.9%

n/

a n/

a98

1 4.

3%

20-2

9 Ye

ars

861

11.2

%

832

11.9

%

792

10.0

%

n/a

n/a

2,48

5 11

.0%

30-3

9 Ye

ars

179

2.3%

18

5 2.

7%

180

2.3%

n/

a n/

a54

4 2.

4%

40-4

9 Ye

ars

62

0.8%

56

0.

8%

73

0.9%

n/

a n/

a19

1 0.

8%

50 a

nd o

ver

18

0.2%

17

0.

2%

31

0.4%

n/

a n/

a66

0.

3%

Unk

now

n n/

a 0.

0%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

n/a

0.0%

Mal

e

Tota

l 1,

447

18.9

%

1,44

320

.7%

1,

383

17.4

%

n/a

n/a

4,27

3 18

.9%

0-12

Yea

rs

3 0.

0%

11

0.2%

8

0.1%

n/

a n/

a22

0.

1%

13-1

9 Ye

ars

2,46

132

.1%

2,

194

31.5

%

2,64

533

.3%

n/

a n/

a7,

300

32.3

%

20-2

9 Ye

ars

3,18

641

.6%

2,

830

40.6

%

3,29

241

.4%

n/

a n/

a9,

308

41.2

%

30-3

9 Ye

ars

465

6.1%

39

0 5.

6%

511

6.4%

n/

a n/

a1,

366

6.1%

40-4

9 Ye

ars

78

1.0%

83

1.

2%

86

1.1%

n/

a n/

a24

7 1.

1%

50 a

nd o

ver

16

0.2%

17

0.

2%

27

0.3%

n/

a n/

a60

0.

3%

Unk

now

n n/

a 0.

0%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

n/a

0.0%

Fem

ale

Tota

l 6,

209

81.1

%

5,52

579

.3%

6,

569

82.6

%

n/a

n/a

18,3

0381

.1%

0-12

Yea

rs

7 0.

1%

13

0.2%

8

0.1%

n/

a n/

a28

0.

1%

13-1

9 Ye

ars

2,78

436

.4%

2,

545

36.5

%

2,95

237

.1%

n/

a n/

a8,

281

36.7

%

20-2

9 Ye

ars

4,04

752

.9%

3,

662

52.6

%

4,08

451

.4%

n/

a n/

a11

,793

52.2

%

30-3

9 Ye

ars

644

8.4%

57

5 8.

3%

691

8.7%

n/

a n/

a1,

910

8.5%

40-4

9 Ye

ars

140

1.8%

13

9 2.

0%

159

2.0%

n/

a n/

a43

8 1.

9%

50 a

nd o

ver

34

0.4%

34

0.

5%

58

0.7%

n/

a n/

a12

6 0.

6%

Unk

now

n n/

a 0.

0%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

n/a

0.0%

Tota

l

Tota

l 7,

656

100.

0%6,

968

100.

0%7,

952

100.

0%n/

a n/

a22

,576

100.

0%

NC

HIV

/STD

Qua

rterly

Sur

veill

ance

Rep

ort V

ol. 2

007

No.

3

NC

DH

HS

HIV

/STD

Pre

v. &

Car

e

11 N

orth

Car

olin

a C

hlam

ydia

Cas

es b

y G

ende

r and

Rac

e/Et

hnic

ity, 2

007

1s

t Qtr

2n

d Q

tr

3rd

Qtr

4t

h Q

tr

Year

to D

ate

RA

CE/

ETH

NIC

ITY

Cas

esPc

t C

ases

Pct

Cas

esPc

t C

ases

Pct

Cas

esPc

t

Whi

te**

27

9 3.

6%

254

3.6%

27

2 3.

4%

n/a

n/a

805

3.6%

Bla

ck**

96

8 12

.6%

90

4 13

.0%

84

4 10

.6%

n/

a n/

a2,

716

12.0

%

Am

.In/A

N**

10

0.1%

10

0.

1%

5 0.

1%

n/a

n/a

25

0.1%

Asi

an,P

I**

10

0.1%

17

0.

2%

11

0.1%

n/

a n/

a38

0.

2%

His

pani

c 11

9 1.

6%

123

1.8%

14

3 1.

8%

n/a

n/a

385

1.7%

Unk

now

n 61

0.

8%

135

1.9%

10

8 1.

4%

n/a

n/a

304

1.3%

Mal

e

Tota

l 1,

447

18.9

%

1,44

320

.7%

1,

383

17.4

%

n/a

n/a

4,27

3 18

.9%

Whi

te**

1,

610

21.0

%

1,27

218

.3%

1,

633

20.5

%

n/a

n/a

4,51

5 20

.0%

Bla

ck**

3,

512

45.9

%

3,00

543

.1%

3,

722

46.8

%

n/a

n/a

10,2

3945

.4%

Am

.In/A

N**

83

1.1%

78

1.

1%

79

1.0%

n/

a n/

a24

0 1.

1%

Asi

an,P

I**

42

0.5%

43

0.

6%

41

0.5%

n/

a n/

a12

6 0.

6%

His

pani

c 43

3 5.

7%

422

6.1%

49

7 6.

3%

n/a

n/a

1,35

2 6.

0%

Unk

now

n 52

9 6.

9%

705

10.1

%

597

7.5%

n/

a n/

a1,

831

8.1%

Fem

ale

Tota

l 6,

209

81.1

%

5,52

579

.3%

6,

569

82.6

%

n/a

n/a

18,3

0381

.1%

Whi

te**

1,

889

24.7

%

1,52

621

.9%

1,

905

24.0

%

n/a

n/a

5,32

0 23

.6%

Bla

ck**

4,

480

58.5

%

3,90

956

.1%

4,

566

57.4

%

n/a

n/a

12,9

5557

.4%

Am

.In/A

N**

93

1.2%

88

1.

3%

84

1.1%

n/

a n/

a26

5 1.

2%

Asi

an,P

I**

52

0.7%

60

0.

9%

52

0.7%

n/

a n/

a16

4 0.

7%

His

pani

c 55

2 7.

2%

545

7.8%

64

0 8.

0%

n/a

n/a

1,73

7 7.

7%

Unk

now

n 59

0 7.

7%

840

12.1

%

705

8.9%

n/

a n/

a2,

135

9.5%

Tota

l

Tota

l 7,

656

100.

0%6,

968

100.

0%7,

952

100.

0%n/

a n/

a22

,576

100.

0%

**

non

His

pani

c; A

m. I

n/AN

= A

mer

ican

Indi

an/A

lask

an N

ativ

e; A

sian

, PI=

Asi

an/P

acifi

c Is

land

er

NC

HIV

/STD

Qua

rterly

Sur

veill

ance

Rep

ort V

ol. 2

007

No.

3

NC

DH

HS

HIV

/STD

Pre

v. &

Car

e

12 N

orth

Car

olin

a G

onor

rhea

Cas

es b

y G

ende

r and

Age

, 200

7

1st Q

tr

2nd

Qtr

3r

d Q

tr

4th

Qtr

Ye

ar to

Dat

e A

GE

Cas

esPc

t C

ases

Pct

Cas

esPc

t C

ases

Pct

Cas

esPc

t

0-12

Yea

rs

n/a

0.0%

n/

a 0.

0%

2 0.

1%

n/a

n/a

2 0.

0%

13-1

9 Ye

ars

266

7.0%

32

7 10

.1%

32

0 10

.5%

n/

a n/

a91

3 9.

1%

20-2

9 Ye

ars

879

23.1

%

919

28.4

%

976

32.1

%

n/a

n/a

2,77

4 27

.5%

30-3

9 Ye

ars

370

9.7%

35

1 10

.9%

36

0 11

.8%

n/

a n/

a1,

081

10.7

%

40-4

9 Ye

ars

191

5.0%

19

0 5.

9%

199

6.6%

n/

a n/

a58

0 5.

8%

50 a

nd o

ver

102

2.7%

10

7 3.

3%

95

3.1%

n/

a n/

a30

4 3.

0%

Unk

now

n 1

0.0%

n/

a 0.

0%

n/a

0.0%

n/

a n/

a1

0.0%

Mal

e

Tota

l 1,

809

47.5

%

1,89

458

.6%

1,

952

64.3

%

n/a

n/a

5,65

5 56

.1%

0-12

Yea

rs

1 0.

0%

6 0.

2%

1 0.

0%

n/a

n/a

8 0.

1%

13-1

9 Ye

ars

689

18.1

%

465

14.4

%

344

11.3

%

n/a

n/a

1,49

8 14

.9%

20-2

9 Ye

ars

1,02

626

.9%

66

3 20

.5%

58

0 19

.1%

n/

a n/

a2,

269

22.5

%

30-3

9 Ye

ars

205

5.4%

14

8 4.

6%

116

3.8%

n/

a n/

a46

9 4.

7%

40-4

9 Ye

ars

71

1.9%

44

1.

4%

37

1.2%

n/

a n/

a15

2 1.

5%

50 a

nd o

ver

9 0.

2%

10

0.3%

5

0.2%

n/

a n/

a24

0.

2%

Unk

now

n n/

a 0.

0%

2 0.

1%

3 0.

1%

n/a

n/a

5 0.

0%

Fem

ale

Tota

l 2,

001

52.5

%

1,33

841

.4%

1,

086

35.7

%

n/a

n/a

4,42

5 43

.9%

0-12

Yea

rs

1 0.

0%

6 0.

2%

3 0.

1%

n/a

n/a

10

0.1%

13-1

9 Ye

ars

955

25.1

%

792

24.5

%

664

21.9

%

n/a

n/a

2,41

1 23

.9%

20-2

9 Ye

ars

1,90

550

.0%

1,

582

48.9

%

1,55

651

.2%

n/

a n/

a5,

043

50.0

%

30-3

9 Ye

ars

575

15.1

%

499

15.4

%

476

15.7

%

n/a

n/a

1,55

0 15

.4%

40-4

9 Ye

ars

262

6.9%

23

4 7.

2%

236

7.8%

n/

a n/

a73

2 7.

3%

50 a

nd o

ver

111

2.9%

11

7 3.

6%

100

3.3%

n/

a n/

a32

8 3.

3%

Unk

now

n 1

0.0%

2

0.1%

3

0.1%

n/

a n/

a6

0.1%

Tota

l

Tota

l 3,

810

100.

0%3,

232

100.

0%3,

038

100.

0%

n/a

n/a

10,0

8010

0.0%

NC

HIV

/STD

Qua

rterly

Sur

veill

ance

Rep

ort V

ol. 2

007

No.

3

NC

DH

HS

HIV

/STD

Pre

v. &

Car

e

13

N

orth

Car

olin

a G

onor

rhea

Cas

es b

y G

ende

r and

Rac

e/Et

hnic

ity, 2

007

1s

t Qtr

2n

d Q

tr

3rd

Qtr

4t

h Q

tr

Year

to D

ate

RA

CE/

ETH

NIC

ITY

Cas

esPc

t C

ases

Pct

Cas

esPc

t C

ases

Pct

Cas

esPc

t

Whi

te**

20

3 5.

3%

189

5.8%

22

3 7.

3%

n/a

n/a

615

6.1%

Bla

ck**

1,

402

36.8

%

1,46

745

.4%

1,

487

48.9

%

n/a

n/a

4,35

6 43

.2%

Am

.In/A

N**

9 0.

2%

18

0.6%

12

0.

4%

n/a

n/a

39

0.4%

Asi

an,P

I**

8 0.

2%

8 0.

2%

6 0.

2%

n/a

n/a

22

0.2%

His

pani

c 53

1.

4%

48

1.5%

79

2.

6%

n/a

n/a

180

1.8%

Unk

now

n 13

4 3.

5%

164

5.1%

14

5 4.

8%

n/a

n/a

443

4.4%

Mal

e

Tota

l 1,

809

47.5

%

1,89

458

.6%

1,

952

64.3

%

n/a

n/a

5,65

5 56

.1%

Whi

te**

41

5 10

.9%

25

1 7.

8%

217

7.1%

n/

a n/

a88

3 8.

8%

Bla

ck**

1,

358

35.6

%

890

27.5

%

685

22.5

%

n/a

n/a

2,93

3 29

.1%

Am

.In/A

N**

19

0.5%

31

1.

0%

14

0.5%

n/

a n/

a64

0.

6%

Asi

an,P

I**

8 0.

2%

4 0.

1%

4 0.

1%

n/a

n/a

16

0.2%

His

pani

c 40

1.

0%

27

0.8%

20

0.

7%

n/a

n/a

87

0.9%

Unk

now

n 16

1 4.

2%

135

4.2%

14

6 4.

8%

n/a

n/a

442

4.4%

Fem

ale

Tota

l 2,

001

52.5

%

1,33

841

.4%

1,

086

35.7

%

n/a

n/a

4,42

5 43

.9%

Whi

te**

61

8 16

.2%

44

0 13

.6%

44

0 14

.5%

n/

a n/

a1,

498

14.9

%

Bla

ck**

2,

760

72.4

%

2,35

772

.9%

2,

172

71.5

%

n/a

n/a

7,28

9 72

.3%

Am

.In/A

N**

28

0.7%

49

1.

5%

26

0.9%

n/

a n/

a10

3 1.

0%

Asi

an,P

I**

16

0.4%

12

0.

4%

10

0.3%

n/

a n/

a38

0.

4%

His

pani

c 93

2.

4%

75

2.3%

99

3.

3%

n/a

n/a

267

2.6%

Unk

now

n 29

5 7.

7%

299

9.3%

29

1 9.

6%

n/a

n/a

885

8.8%

Tota

l

Tota

l 3,

810

100.

0%3,

232

100.

0%3,

038

100.

0%n/

a n/

a10

,080

100.

0%

**n

on H

ispa

nic;

Am

. In/

AN

= A

mer

ican

Indi

an/A

lask

an N

ativ

e; A

sian

, PI=

Asi

an/P

acifi

c Is

land

er

NC

HIV

/STD

Qua

rterly

Sur

veill

ance

Rep

ort V

ol. 2

007

No.

3

NC

DH

HS

HIV

/STD

Pre

v. &

Car

e

14 N

orth

Car

olin

a Ea

rly S

yphi

lis C

ases

by

Gen

der a

nd A

ge, 2

007

1s

t Qtr

2n

d Q

tr

3rd

Qtr

4t

h Q

tr

Year

to D

ate

AG

E C

ases

Pct

Cas

esPc

t C

ases

Pct

Cas

esPc

tC

ases

Pct

0-12

Yea

rs

n/a

0.0%

n/

a 0.

0%

n/a

0.0%

n/

a n/

an/

a 0.

0%

13-1

9 Ye

ars

6 3.

8%

6 4.

3%

6 5.

2%

n/a

n/a

18

4.4%

20-2

9 Ye

ars

36

22.6

%

25

18.0

%

29

25.2

%

n/a

n/a

90

21.8

%

30-3

9 Ye

ars

28

17.6

%

33

23.7

%

20

17.4

%

n/a

n/a

81

19.6

%

40-4

9 Ye

ars

33

20.8

%

25

18.0

%

14

12.2

%

n/a

n/a

72

17.4

%

50 a

nd o

ver

15

9.4%

12

8.

6%

8 7.

0%

n/a

n/a

35

8.5%

Unk

now

n n/

a 0.

0%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

n/a

0.0%

Mal

e

Tota

l 11

8 74

.2%

10

1 72

.7%

77

67

.0%

n/

a n/

a29

6 71

.7%

0-12

Yea

rs

n/a

0.0%

n/

a 0.

0%

n/a

0.0%

n/

a n/

an/

a 0.

0%

13-1

9 Ye

ars

1 0.

6%

3 2.

2%

2 1.

7%

n/a

n/a

6 1.

5%

20-2

9 Ye

ars

14

8.8%

12

8.

6%

15

13.0

%

n/a

n/a

41

9.9%

30-3

9 Ye

ars

10

6.3%

13

9.

4%

11

9.6%

n/

a n/

a34

8.

2%

40-4

9 Ye

ars

14

8.8%

7

5.0%

10

8.

7%

n/a

n/a

31

7.5%

50 a

nd o

ver

2 1.

3%

3 2.

2%

n/a

0.0%

n/

a n/

a5

1.2%

Unk

now

n n/

a 0.

0%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

n/a

0.0%

Fem

ale

Tota

l 41

25

.8%

38

27

.3%

38

33

.0%

n/

a n/

a11

7 28

.3%

0-12

Yea

rs

n/a

0.0%

n/

a 0.

0%

n/a

0.0%

n/

a n/

an/

a 0.

0%

13-1

9 Ye

ars

7 4.

4%

9 6.

5%

8 7.

0%

n/a

n/a

24

5.8%

20-2

9 Ye

ars

50

31.4

%

37

26.6

%

44

38.3

%

n/a

n/a

131

31.7

%

30-3

9 Ye

ars

38

23.9

%

46

33.1

%

31

27.0

%

n/a

n/a

115

27.8

%

40-4

9 Ye

ars

47

29.6

%

32

23.0

%

24

20.9

%

n/a

n/a

103

24.9

%

50 a

nd o

ver

17

10.7

%

15

10.8

%

8 7.

0%

n/a

n/a

40

9.7%

Unk

now

n n/

a 0.

0%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

n/a

0.0%

Tota

l

Tota

l 15

9 10

0.0%

139

100.

0%11

5 10

0.0%

n/

a n/

a41

3 10

0.0%

NC

HIV

/STD

Qua

rterly

Sur

veill

ance

Rep

ort V

ol. 2

007

No.

3

NC

DH

HS

HIV

/STD

Pre

v. &

Car

e

15 N

orth

Car

olin

a Ea

rly S

yphi

lis C

ases

by

Gen

der a

nd R

ace/

Ethn

icity

, 200

7

1st Q

tr

2nd

Qtr

3r

d Q

tr

4th

Qtr

Ye

ar to

Dat

e R

AC

E/ET

HN

ICIT

Y C

ases

Pct

Cas

esPc

t C

ases

Pct

Cas

esPc

tC

ases

Pct

Whi

te**

33

20

.8%

20

14

.4%

16

13

.9%

n/

a n/

a69

16

.7%

Bla

ck**

77

48

.4%

79

56

.8%

52

45

.2%

n/

a n/

a20

8 50

.4%

Am

.In/A

N**

2 1.

3%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

2 0.

5%

Asi

an,P

I**

1 0.

6%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

1 0.

2%

His

pani

c 5

3.1%

1

0.7%

8

7.0%

n/

a n/

a14

3.

4%

Unk

now

n n/

a 0.

0%

1 0.

7%

1 0.

9%

n/a

n/a

2 0.

5%

Mal

e

Tota

l 11

8 74

.2%

10

1 72

.7%

77

67

.0%

n/

a n/

a29

6 71

.7%

Whi

te**

4

2.5%

10

7.

2%

10

8.7%

n/

a n/

a24

5.

8%

Bla

ck**

36

22

.6%

24

17

.3%

23

20

.0%

n/

a n/

a83

20

.1%

Am

.In/A

N**

n/a

0.0%

1

0.7%

1

0.9%

n/

a n/

a2

0.5%

Asi

an,P

I**

n/a

0.0%

1

0.7%

n/

a 0.

0%

n/a

n/a

1 0.

2%

His

pani

c 1

0.6%

2

1.4%

4

3.5%

n/

a n/

a7

1.7%

Unk

now

n n/

a 0.

0%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

n/a

0.0%

Fem

ale

Tota

l 41

25

.8%

38

27

.3%

38

33

.0%

n/

a n/

a11

7 28

.3%

Whi

te**

37

23

.3%

30

21

.6%

26

22

.6%

n/

a n/

a93

22

.5%

Bla

ck**

11

3 71

.1%

10

3 74

.1%

75

65

.2%

n/

a n/

a29

1 70

.5%

Am

.In/A

N**

2 1.

3%

1 0.

7%

1 0.

9%

n/a

n/a

4 1.

0%

Asi

an,P

I**

1 0.

6%

1 0.

7%

n/a

0.0%

n/

a n/

a2

0.5%

His

pani

c 6

3.8%

3

2.2%

12

10

.4%

n/

a n/

a21

5.

1%

Unk

now

n n/

a 0.

0%

1 0.

7%

1 0.

9%

n/a

n/a

2 0.

5%

Tota

l

Tota

l 15

9 10

0.0%

139

100.

0%11

5 10

0.0%

n/a

n/a

413

100.

0%

**

non

His

pani

c; A

m. I

n/AN

= A

mer

ican

Indi

an/A

lask

an N

ativ

e; A

sian

, PI=

Asi

an/P

acifi

c Is

land

er

NC

HIV

/STD

Qua

rterly

Sur

veill

ance

Rep

ort V

ol. 2

007

No.

3

NC

DH

HS

HIV

/STD

Pre

v. &

Car

e

16 N

orth

Car

olin

a A

IDS

Cas

es b

y G

ende

r and

Age

, 200

7

1st Q

tr

2nd

Qtr

3r

d Q

tr

4th

Qtr

Ye

ar to

Dat

e A

GE

Cas

esPc

t C

ases

Pct

Cas

esPc

t C

ases

Pct

Cas

esPc

t

0-12

Yea

rs

n/a

0.0%

n/

a 0.

0%

n/a

0.0%

n/

a n/

an/

a 0.

0%

13-1

9 Ye

ars

1 0.

4%

1 0.

4%

3 1.

4%

n/a

n/a

5 0.

7%

20-2

9 Ye

ars

26

10.3

%

26

11.1

%

18

8.5%

n/

a n/

a70

10

.0%

30-3

9 Ye

ars

41

16.2

%

44

18.8

%

37

17.5

%

n/a

n/a

122

17.5

%

40-4

9 Ye

ars

68

26.9

%

69

29.5

%

55

26.1

%

n/a

n/a

192

27.5

%

50 a

nd o

ver

37

14.6

%

32

13.7

%

34

16.1

%

n/a

n/a

103

14.8

%

Mal

e

Tota

l 17

3 68

.4%

17

2 73

.5%

14

7 69

.7%

n/

a n/

a49

2 70

.5%

0-12

Yea

rs

n/a

0.0%

1

0.4%

n/

a 0.

0%

n/a

n/a

1 0.

1%

13-1

9 Ye

ars

n/a

0.0%

n/

a 0.

0%

2 0.

9%

n/a

n/a

2 0.

3%

20-2

9 Ye

ars

6 2.

4%

5 2.

1%

11

5.2%

n/

a n/

a22

3.

2%

30-3

9 Ye

ars

25

9.9%

14

6.

0%

22

10.4

%

n/a

n/a

61

8.7%

40-4

9 Ye

ars

33

13.0

%

27

11.5

%

19

9.0%

n/

a n/

a79

11

.3%

50 a

nd o

ver

16

6.3%

15

6.

4%

10

4.7%

n/

a n/

a41

5.

9%

Fem

ale

Tota

l 80

31

.6%

62

26

.5%

64

30

.3%

n/

a n/

a20

6 29

.5%

0-12

Yea

rs

n/a

0.0%

1

0.4%

n/

a 0.

0%

n/a

n/a

1 0.

1%

13-1

9 Ye

ars

1 0.

4%

1 0.

4%

5 2.

4%

n/a

n/a

7 1.

0%

20-2

9 Ye

ars

32

12.6

%

31

13.2

%

29

13.7

%

n/a

n/a

92

13.2

%

30-3

9 Ye

ars

66

26.1

%

58

24.8

%

59

28.0

%

n/a

n/a

183

26.2

%

40-4

9 Ye

ars

101

39.9

%

96

41.0

%

74

35.1

%

n/a

n/a

271

38.8

%

50 a

nd o

ver

53

20.9

%

47

20.1

%

44

20.9

%

n/a

n/a

144

20.6

%

Tota

l

Tota

l 25

3 10

0.0%

234

100.

0%21

1 10

0.0%

n/

a n/

a69

8 10

0.0%

NC

HIV

/STD

Qua

rterly

Sur

veill

ance

Rep

ort V

ol. 2

007

No.

3

NC

DH

HS

HIV

/STD

Pre

v. &

Car

e

17 N

orth

Car

olin

a A

IDS

Cas

es b

y G

ende

r and

Rac

e/Et

hnic

ity, 2

007

1s

t Qtr

2n

d Q

tr

3rd

Qtr

4t

h Q

tr

Year

to D

ate

RA

CE/

ETH

NIC

ITY

Cas

esPc

t C

ases

Pct

Cas

esPc

t C

ases

Pct

Cas

esPc

t

Whi

te**

36

14

.2%

39

16

.7%

37

17

.5%

n/

a n/

a11

2 16

.0%

Bla

ck**

11

5 45

.5%

11

5 49

.1%

94

44

.5%

n/

a n/

a32

4 46

.4%

Am

.In/A

N**

3 1.

2%

1 0.

4%

n/a

0.0%

n/

a n/

a4

0.6%

Asi

an,P

I**

1 0.

4%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

1 0.

1%

His

pani

c 18

7.

1%

17

7.3%

15

7.

1%

n/a

n/a

50

7.2%

Unk

now

n n/

a 0.

0%

n/a

0.0%

1

0.5%

n/

a n/

a1

0.1%

Mal

e

Tota

l 17

3 68

.4%

17

2 73

.5%

14

7 69

.7%

n/

a n/

a49

2 70

.5%

Whi

te**

16

6.

3%

6 2.

6%

7 3.

3%

n/a

n/a

29

4.2%

Bla

ck**

57

22

.5%

52

22

.2%

55

26

.1%

n/

a n/

a16

4 23

.5%

Am

.In/A

N**

2 0.

8%

2 0.

9%

2 0.

9%

n/a

n/a

6 0.

9%

Asi

an,P

I**

n/a

0.0%

1

0.4%

n/

a 0.

0%

n/a

n/a

1 0.

1%

His

pani

c 5

2.0%

1

0.4%

n/

a 0.

0%

n/a

n/a

6 0.

9%

Unk

now

n n/

a 0.

0%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

n/a

0.0%

Fem

ale

Tota

l 80

31

.6%

62

26

.5%

64

30

.3%

n/

a n/

a20

6 29

.5%

Whi

te**

52

20

.6%

45

19

.2%

44

20

.9%

n/

a n/

a14

1 20

.2%

Bla

ck**

17

2 68

.0%

16

7 71

.4%

14

9 70

.6%

n/

a n/

a48

8 69

.9%

Am

.In/A

N**

5 2.

0%

3 1.

3%

2 0.

9%

n/a

n/a

10

1.4%

Asi

an,P

I**

1 0.

4%

1 0.

4%

n/a

0.0%

n/

a n/

a2

0.3%

His

pani

c 23

9.

1%

18

7.7%

15

7.

1%

n/a

n/a

56

8.0%

Unk

now

n n/

a 0.

0%

n/a

0.0%

1

0.5%

n/

a n/

a1

0.1%

Tota

l

Tota

l 25

3 10

0.0%

234

100.

0%21

1 10

0.0%

n/

a n/

a69

8 10

0.0%

*

*non

His

pani

c; A

m. I

n/A

N=

Am

eric

an In

dian

/Ala

skan

Nat

ive;

Asi

an, P

I= A

sian

/Pac

ific

Isla

nder

NC

HIV

/STD

Qua

rterly

Sur

veill

ance

Rep

ort V

ol. 2

007

No.

3

NC

DH

HS

HIV

/STD

Pre

v. &

Car

e

18

Nor

th C

arol

ina

AID

S C

ases

by

Gen

der a

nd M

ode

of T

rans

mis

sion

, 200

7

1st Q

tr

2nd

Qtr

3r

d Q

tr

4th

Qtr

Ye

ar to

Dat

e M

OD

E O

F TR

AN

SMIS

SIO

N

Cas

esPc

t C

ases

Pct

Cas

es

Pct

Cas

esPc

tC

ases

Pct

MSM

**

65

25.7

%

61

26.1

%

57

27.0

%

n/a

n/a

183

26.2

%

IDU

**

12

4.7%

7

3.0%

11

5.

2%

n/a

n/a

30

4.3%

MSM

/IDU

6

2.4%

7

3.0%

4

1.9%

n/

a n/

a17

2.

4%

Blo

od P

rodu

cts*

* 1

0.4%

1

0.4%

n/

a 0.

0%

n/a

n/a

2 0.

3%

Het

eros

exua

l con

tact

9

3.6%

13

5.

6%

11

5.2%

n/

a n/

a33

4.

7%

Pres

umed

het

eros

exua

l32

12

.6%

27

11

.5%

18

8.

5%

n/a

n/a

77

11.0

%

Pedi

atric

n/

a 0.

0%

n/a

0.0%

n/

a 0.

0%

n/a

n/a

n/a

0.0%

Ris

k no

t spe

cifie

d 48

19

.0%

56

23

.9%

46

21

.8%

n/

a n/

a15

0 21

.5%

Mal

e

Tota

l 17

3 68

.4%

17

2 73

.5%

14

7 69

.7%

n/

a n/

a49

2 70

.5%

IDU

**

6 2.

4%

7 3.

0%

5 2.

4%

n/a

n/a

18

2.6%

Blo

od P

rodu

cts*

* 2

0.8%

2

0.9%

2

0.9%

n/

a n/

a6

0.9%

Het

eros

exua

l con

tact

28

11

.1%

16

6.

8%

19

9.0%

n/

a n/

a63

9.

0%

Pres

umed

het

eros

exua

l15

5.

9%

13

5.6%

17

8.

1%

n/a

n/a

45

6.4%

Pedi

atric

n/

a 0.

0%

1 0.

4%

1 0.

5%

n/a

n/a

2 0.

3%

Ris

k no

t spe

cifie

d 29

11

.5%

23

9.

8%

20

9.5%

n/

a n/

a72

10

.3%

Fem

ale

Tota

l 80

31

.6%

62

26

.5%

64

30

.3%

n/

a n/

a20

6 29

.5%

MSM

**

65

25.7

%

61

26.1

%

57

27.0

%

n/a

n/a

183

26.2

%

IDU

**

18

7.1%

14

6.

0%

16

7.6%

n/

a n/

a48

6.

9%

MSM

/IDU

6

2.4%

7

3.0%

4

1.9%

n/

a n/

a17

2.

4%

Blo

od P

rodu

cts*

* 3

1.2%

3

1.3%

2

0.9%

n/

a n/

a8

1.1%

Het

eros

exua

l con

tact

37

14

.6%

29

12

.4%

30

14

.2%

n/

a n/

a96

13

.8%

Pres

umed

het

eros

exua

l47

18

.6%

40

17

.1%

35

16

.6%

n/

a n/

a12

2 17

.5%

Pedi

atric

n/

a 0.

0%

1 0.

4%

1 0.

5%

n/a

n/a

2 0.

3%

Ris

k no

t spe

cifie

d 77

30

.4%

79

33

.8%

66

31

.3%

n/

a n/

a22

2 31

.8%

Tota

l

Tota

l 25

3 10

0.0%

234

100.

0%21

1 10

0.0%

n/a

n/a

698

100.

0%

**M

SM

= m

en w

ho h

ave

sex

with

men

; ID

U=

intra

veno

us d

rug

use;

“Blo

od p

rodu

cts”

incl

udes

adu

lt he

mop

hilia

; “P

resu

med

het

eros

exua

l” in

clud

es

repo

rts in

itial

ly c

lass

ified

as

“ris

k no

t sp

ecifi

ed ”

with

add

ition

al ri

sk in

form

atio

n co

nsis

tent

with

het

eros

exua

l tra

nsm

issi

on